Paper Details

  1. Home
  2. Paper Details

Influence of methazolamide on the human control of breathing: A comparison to acetazolamide.

Author: BouletLindsey M, CheyneWilliam S, DominelliGiulio S, DominelliPaolo B, FosterGlen E, HackettHeather K, SwensonErik R, TeppemaLuc J

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study investigates the effects of methazolamide, a carbonic anhydrase inhibitor, on respiratory control in humans. It finds that methazolamide, similar to acetazolamide, causes a metabolic acidosis and shifts the ventilatory CO2 response curve leftwards without impairing oxygen sensitivity. It suggests that methazolamide could be a valuable alternative to acetazolamide in treating certain respiratory conditions.
Paper Details　
Original Abstract of the Article :
xmlns:ns0="http://www.w3.org/1998/Math/MathML" Label="NEW FINDINGS">What is the central question of this study? Acetazolamide and methazolamide both reduce hypoxic pulmonary vasoconstriction equally, but methazolamide does not impair skeletal muscle function. The effect of methazolamide on respirato...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1113/EP088058

データ提供：米国国立医学図書館（NLM）

Methazolamide: A New Oasis in the Desert of Hypoxic Pulmonary Vasoconstriction

The world of respiratory medicine is often a complex desert of challenges, with conditions like hypoxic pulmonary vasoconstriction (HPV) requiring careful navigation. This study explored the effects of methazolamide, a drug commonly used to treat glaucoma, on respiratory control in humans. They compared methazolamide to acetazolamide, another drug that also reduces HPV. Their findings suggest that methazolamide, like a refreshing oasis, might offer a unique advantage in managing HPV without compromising skeletal muscle function.

Respiratory Control: Unraveling the Mysteries of the Desert

The study found that methazolamide, similar to acetazolamide, caused a metabolic acidosis and shifted the ventilatory CO2 response curve leftwards without reducing O2 sensitivity. These findings suggest that methazolamide might have a distinct mechanism of action compared to acetazolamide, offering a new avenue for managing HPV with fewer potential side effects.

Health Implications: Navigating the Desert of Respiratory Challenges

This research provides valuable insights into the potential of methazolamide for managing HPV. It's like discovering a new path in the desert, one that could lead to improved respiratory health with fewer potential obstacles. Further research is needed to fully understand the long-term effects of methazolamide and its role in managing HPV, but these findings offer a promising direction for future exploration.

Dr.Camel's Conclusion

This study presents a compelling case for exploring methazolamide as a potential therapeutic option for managing HPV. It's like finding a new oasis in the vast desert of respiratory research, offering a glimmer of hope for improving the lives of those struggling with this challenging condition.

Date :
  1. Date Completed 2021-07-28
  2. Date Revised 2021-07-28
Further Info :

Pubmed ID

31595565

DOI: Digital Object Identifier

10.1113/EP088058

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.